No Data
No Data
No Data
No Data
No Data
Rafarma Pharmaceuticals plans to increase presence in Central Asia
Rafarma Pharmaceuticals (OTCPK:RAFA) plans to increase its presence in Central Asia by creating local production. The company's representatives visited Uzbekistan and discussed the prospects for the c
Seeking AlphaApr 29, 2022 09:42 ET
Rafarma Pharmaceuticals strengthens its position in Central Asia
Nicosia, Cyprus, April 29, 2022 (GLOBE NEWSWIRE) -- Representatives of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) visited Uzbekistan and discussed the prospects for the company's development in the t
GlobeNewswireApr 29, 2022 09:25 ET
Rafarma’s Slavich Noya Technology Division Expands Printing Production
Nicosia, Cyprus, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) Slavich Noya Technology, part of the Rafarma Pharmaceuticals group of companies, is expanding its producti
GlobeNewswireFeb 7, 2022 09:21 ET
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research
Nicosia, Cyprus, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international intergover
GlobeNewswireDec 21, 2021 10:56 ET
RAFA To Add Major Component to the Tashkent Pharma Park
Nicosia, Cyprus, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and the Czech company "Block" signed an agreement on the implementation of the construction of a scientifi
GlobeNewswireDec 17, 2021 11:36 ET
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5
Nicosia, Cyprus, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that PJSC Kraspharma at the end of 2020 entered the TOP-5 of the most dynamic and largest pharmace
GlobeNewswireNov 19, 2021 09:30 ET
No Data
No Data